How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

The biggest slump in a month for US stocks is leading investors to question whether long-running concerns over lofty tech ...

Risky assets slid, with tech stocks and cryptocurrencies bearing the brunt of the selling, after long-simmering concerns ...

Finally, after months of leaks, teasers and even an unveiling at the recent ASEAN Summit, Proton has finally revealed the new ...

For nearly a decade, despite regular visits to my GP practice where I detailed the pain I was experiencing, no one seemed to ...

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The ...

Merck's enlicitide pill lowered LDL cholesterol by up to 60%, matching injectables like Repatha and offering an easier option ...

The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.

At 12 weeks, a combination pill containing candesartan cilexetil, amlodipine, and chlorthalidone improved BP in patients with hypertension.

The 72-week multinational phase 3 ATTAIN-2 trial randomized 1613 participants with obesity or overweight (BMI ≥ 27.0) and T2D ...

Lilly said the plant will strengthen its global supply chain and expand the capacity for its growing portfolio of oral ...